Respiratory Syncytial Virus

Since Seasonal Respiratory Viruses are Alive and Well, It's Smart to Take Precautions

The level of respiratory illnesses in the U.S. is high and increasing. We are again experiencing a "tripledemic" of COVID-19, flu, and respiratory syncytial virus (RSV). As the peak incidence of those infections approaches, we should be vigilant and take appropriate precautions.
Read more

First FDA-Approved RSV Vaccines Prevent Respiratory Infections That Pose Serious Hazards to Older Adults

The virus leads to approximately 60,000-120,000 hospitalizations and 6,000-10,000 deaths yearly in people over 65 in the U.S. It also threatens young children and pediatric vaccine approvals are expected soon.
Read more